Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

With clear, enforceable regulations, the potential sale or acquisition of the 23andme data would be far less perilous, ensuring that the benefits of genomic research are achieved without ...

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...

23andMe can display the results in a timeline ... Some of these are also currently on sale but are listed below at their retail price. Ancestry is best known for its family tree feature.

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe faced major hurdles in 2024 ... which The Atlantic reported could include the sale of their personal genetic data. Wojcicki walked back her remark in a separate filing.

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations ...